Celon Pharma Balance Sheet Health
Financial Health criteria checks 6/6
Celon Pharma has a total shareholder equity of PLN516.2M and total debt of PLN0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are PLN619.2M and PLN102.9M respectively. Celon Pharma's EBIT is PLN22.4M making its interest coverage ratio 3.8. It has cash and short-term investments of PLN24.9M.
Key information
0%
Debt to equity ratio
zł0
Debt
| Interest coverage ratio | 3.8x |
| Cash | zł24.92m |
| Equity | zł516.25m |
| Total liabilities | zł102.91m |
| Total assets | zł619.15m |
Recent financial health updates
Celon Pharma (WSE:CLN) Is In A Good Position To Deliver On Growth Plans
Jul 13
We're Interested To See How Celon Pharma (WSE:CLN) Uses Its Cash Hoard To Grow
Nov 04We Think Celon Pharma (WSE:CLN) Can Afford To Drive Business Growth
Aug 04Celon Pharma (WSE:CLN) Seems To Use Debt Quite Sensibly
May 23Celon Pharma (WSE:CLN) Has A Pretty Healthy Balance Sheet
Dec 03Recent updates
A Piece Of The Puzzle Missing From Celon Pharma S.A.'s (WSE:CLN) Share Price
Aug 21Earnings Update: Celon Pharma S.A. (WSE:CLN) Just Reported And Analysts Are Boosting Their Estimates
Sep 24Celon Pharma (WSE:CLN) Is In A Good Position To Deliver On Growth Plans
Jul 13We're Interested To See How Celon Pharma (WSE:CLN) Uses Its Cash Hoard To Grow
Nov 04We Think Celon Pharma (WSE:CLN) Can Afford To Drive Business Growth
Aug 04Celon Pharma (WSE:CLN) Seems To Use Debt Quite Sensibly
May 23Calculating The Intrinsic Value Of Celon Pharma S.A. (WSE:CLN)
Mar 02Celon Pharma S.A. (WSE:CLN) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?
Feb 09
Celon Pharma's (WSE:CLN) Earnings Are Growing But Is There More To The Story?
Jan 20Celon Pharma (WSE:CLN) Shareholders Have Enjoyed A 12% Share Price Gain
Dec 24Celon Pharma (WSE:CLN) Has A Pretty Healthy Balance Sheet
Dec 03Financial Position Analysis
Short Term Liabilities: CLN's short term assets (PLN193.3M) exceed its short term liabilities (PLN72.3M).
Long Term Liabilities: CLN's short term assets (PLN193.3M) exceed its long term liabilities (PLN30.6M).
Debt to Equity History and Analysis
Debt Level: CLN is debt free.
Reducing Debt: CLN had no debt 5 years ago.
Debt Coverage: CLN has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: CLN has no debt, therefore coverage of interest payments is not a concern.